secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0000950170-23-057737
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker Q3: Rev $742.8M, Non-GAAP EPS $0.74, FY organic guidance raised to 11.5-12.5%
--------------------------------------------------------------------------------

- Q3 revenue $742.8M (+16.3% YoY); organic +10.9%, acquisitions +2.1%, FX +3.3%.
- Q3 GAAP EPS $0.60; Non-GAAP EPS $0.74 (+12.1% YoY).
- BSI segment revenue $676.3M (+16.1% YoY); BEST segment $70.6M (+19.1%).
- FY 2023 revenue guidance raised to $2.88-$2.91B; organic growth 11.5-12.5% (+150 bps midpoint).
- Cellular Analysis (PhenomeX) acquired Oct 2; slightly dilutive in FY24, accretive by FY26.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000095017023057737/0000950170-23-057737-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000095017023057737/brkr-20231102.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-057737

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer